Conjunctivitis  >>  tobramycin/dexamethasone  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tobramycin/dexamethasone / Generic mfg.
ChiCTR-IIR-17014018: The clinical research of safety and effectiveness of Tobrdex (0.3% and 0.1% tobramycin dexamethasone ophthalmic suspension) as control, Zylet (0.5% loteprednol and 0.3% tobramycin ophthalmic suspension) treatment blepharo-keratoconjunctivitis

Completed
1
344
 
Zylet (0.5% loteprednol and 0.3% tobramycin ophthalmic suspension) ;Tobrdex (0.3% and 0.1% tobramycin dexamethasone ophthalmic suspension)
Eye Hospital of Wenzhou Medical University; Bausch & Lomb Limited by Share Ltd, company
blepharo-keratoconjunctivitis
 
 
NCT03975374: To Study Efficacy and Safety of Tobradex Eye Drop Suspension vs Tobramycin/Dexamethasone Ophthalmic Suspension

Unknown status
1
5000
US
Tobramycin/dexamethasone opthalmic solution, Tobradex, Tobradex Opthalmic Solution
Sutphin Drugs
Blepharo Conjunctivitis
07/19
06/20

Download Options